Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Non-Current Deffered Revenue came in at $8.8 million in Q1 2026, up 16253.7% on a QoQ basis from $54000.0 in Q4 2018.
Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 10 years of Non-Current Deffered Revenue data on file, last reported at $8.8 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (changed N/A YoY) and the FY2018 annual result came in at $54000.0, down 65.16% from the prior year.
- Non-Current Deffered Revenue rose to $8.8 million in Q1 2026, from $54000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $8.8 million in Q1 2026 to a low of $8.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.43 Bn | 2.08 Bn | 214.41 Mn | 13.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.46 Mn |
| Mar 31, 2026 | 8.83 Mn |
| Dec 31, 2018 | 54,000.00 |
| Sep 30, 2018 | 81,000.00 |
| Jun 30, 2018 | 107,000.00 |
| Mar 31, 2018 | 131,000.00 |
| Dec 31, 2017 | 155,000.00 |
| Sep 30, 2017 | 178,000.00 |
| Jun 30, 2017 | 201,000.00 |
| Mar 31, 2017 | 223,000.00 |
| Dec 31, 2016 | 244,000.00 |
| Sep 30, 2016 | 265,000.00 |
| Jun 30, 2016 | 8.78 Mn |
| Mar 31, 2016 | 313,000.00 |
| Dec 31, 2015 | 329,000.00 |
| Sep 30, 2015 | 345,000.00 |
| Jun 30, 2015 | 361,000.00 |
| Mar 31, 2015 | 3.26 Mn |
| Dec 31, 2014 | 394,000.00 |
| Sep 30, 2014 | 3.85 Mn |